Overview
- 17 inspections across 17 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2016-04-22.
At a glance
Inspections
17
Sites
17
Observations
3
Career since
May 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Immunex Rhode Island Corporation | 22 Apr 2016 | Human Drugs | On file |
| Boehringer Ingelheim Pharma GmbH and Co. KG | 11 Aug 2015 | Human Drugs | On file |
| BioVectra Inc | 17 Apr 2015 | Human Drugs | On file |
| LONZA BIOLOGICS TUAS PTE. LTD. | 10 Mar 2015 | Human Drugs | On file |
| MSD Ireland (Carlow) | 19 Nov 2014 | Human Drugs |
Sites inspected
Immunex Rhode Island CorporationWest Greenwich, United States1 insp.
Boehringer Ingelheim Pharma GmbH and Co. KGBiberach An Der Ris, Germany1 insp.
BioVectra IncCharlottetown, Canada1 insp.
LONZA BIOLOGICS TUAS PTE. LTD.Singapore, Singapore1 insp.
MSD Ireland (Carlow)Carlow, Ireland1 insp.
Co-investigators
Investigators who share inspections with this person.
Reyes Candau-Chacon2 shared
Bo Chi2 shared
Kristy A Zielny2 shared
Maria J Lopez- Barragan1 shared
Sam Pepe1 shared
Wayne E Seifert1 shared
Santos E Camara1 shared
Erika V Butler1 shared
Brian D Nicholson1 shared
Thuy T Nguyen1 shared
Full investigator report
Get the verbatim findings behind Donald C Obenhuber's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site